To identify mechanisms involved in the increased proliferation and reduced doxorubicin sensitivity of neuroblastoma cells with TRPM2 expression compared to cells with TRPM2 deletion, the focus of this manuscript, we first examined genes involved in cell cycle progression. This evidence concerns the gene TRPM2 and neuroblastoma.